The rumors were right about UnitedHealth Group stock

Rumor that Berkshire would buy UNH proved true.
Berkshire Hathaway purchased 5.04 million shares in Q2.
UNH stock surges 10% on the news after 13F filing.
Support for UNH should readjust back to $300.

Clay Webster FXStreet

After plunging to a five-year low on August 1 at $234.60, the rumor began to circulate that UnitedHealth Group (UNH), the largest private health insurer in the US, might be saved by Warren Buffet's Berkshire Hathaway (BRK-A, BRK-B). While the Oracle of Omaha has opted to retire from his behemoth holding company at the end of the year, it appears he had one large trade still in him.

Berkshire's 13F filing late Thursday shows that it purchased 5.04 million shares of UNH in the second quarter that ended on June 30. The new $1.57 billion position has deteriorated since then, with shares dropping well below its average purchase price of $311.97, but Berkshire has a long history of adding to its positions. Investors will now think that the share price is backstopped by Berkshire's large buying ability.

UNH shares jumped 10.5% in the first few minutes of trading, returning to $300 a share for the first time since July 15.

The Dow Jones Industrial Average (DJIA) has gained 0.5% despite the NASDAQ shedding weight moderately. The market is a bit tepid on Friday after President Donald Trump downplayed Friday's meeting with Russian President Vladimir Putin and US Retail Sales in July arrived in line at 0.5% MoM. Trump is also threatening to institute new tariffs on semiconductor imports.

UnitedHealth Group stock news

UnitedHealth Group is a dividend growth stalwart much in line with Berkshire's history of interest in insurance investments. Investors are not being foolhardy in the hope that Berkshire continues buying while UNH trades at 50% off its all-time high of $630.

Alongside UNH, Berkshire started new positions during Q2 in steelmaker Nucor (NUE) and homebuilder DR Horton (DHI). But neither reached the billion-dollar level of UNH. In order to fund the purchases, Berkshire continued selling shares of Apple (AAPL) and Bank of America (BAC).

While the Justice Department continues to investigate UnitedHealth for alleged Medicare fraud and the insurer deals with higher-than-expected medical cost ratios, the share price will remain subdued overall. But Berkshire's purchase alongside many other hedge funds in Q2 makes the stock look attractive to many bargain hunters.

To make up for those higher medical usage and cost ratios, insurers are asking for an average 15% rise in Affordable Care Act (ACA) exchange plans for 2026, and some insurers have filed for premium hikes of as much as 37%. While these hikes may not be approved, most expect UnitedHealth's business to be on much firmer ground in 2026.

UnitedHealth Group stock forecast

While they wait for the health insurance industry to right the ship, investors can expect UNH to start utilizing the $300 psychological level as a recovered support level. This is where the share price largely held up since UnitedHealth's former CEO, Andrew Witty, resigned in May amid the worrisome cost increase.

Now trading above the 50-day Simple Moving Average (SMA) for the first time since April 16, bulls will target resistance at $342.00 and eventually aim to fill the gap up to $376.84. The worst of the sell-off will be over only when UNH recovers the $438.50 former support level.

UNH daily stock chart

Author

Clay Webster

FXStreet

Clay Webster grew up in the US outside Buffalo, New York and Lancaster, Pennsylvania. He began investing after college following the 2008 financial crisis.

AUD/USD sits near monthly high, around 0.7035 on hawkish RBA

AUD/USD trades around 0.7030-0.7035 in the Asian session on Thursday, near its monthly top, as recent hawkish comments from RBA officials continue to underpin the Australian Dollar. The US Dollar, meanwhile, struggles to lure buyers amid further declines in US bond yields, adding support to the pair. However, Fed rate-hike bets and geopolitical uncertainty help limit losses for the safe-haven buck, warranting caution for Aussie bulls.

USD/JPY remains confined in a familiar range; holds steady above 158.00

USD/JPY extends its consolidative price action through Thursday's Asian session, trading just above 158.00 amid diverging forces. Uncertainty over the timing of the next BoJ rate hike keeps Japanese Yen bulls on the defensive. The US Dollar, meanwhile, languishes near multi-week low amid declining US bond yields. Furthermore, looming intervention risks limit JPY losses and cap the pair. Traders also seem hesitant ahead of the Fed and BoJ meetings next week.

Gold hangs near one-week low; eyes $4,100 break amid Fed hike bets

Gold attracts fresh sellers in Thursday’s Asian session, sliding closer to a one-week low touched the previous day. Firming expectations for an imminent Fed rate hike, bolstered by oil-driven inflation risks, weigh on the non-yielding bullion. Meanwhile, declining US bond yields counter geopolitical uncertainty, keeping US Dollar bulls on the defensive. This helps XAU/USD defend $4,100.

Dogecoin Labs launches, resistance looms

Dogecoin (DOGE) Labs launched Wednesday in partnership with the Dogecoin Foundation, bringing together several product teams and technologies to expand the use of the memecoin (DOGE) across payments, decentralized finance (DeFi) and consumer applications. The launch will consolidate MyDoge, DogeOS and Such App under one business, led by Jordan Jefferson, founder of MyDoge and DogeOS.

What the midterm elections mean for Treasury yields, the Dollar and Gold

Democrats are priced to take the House, so November 3 comes down to the Senate and how much Washington can borrow without the other party. Treasury yields will show the answer first, then the Dollar and Gold. On November 3, Americans vote for all 435 House seats and 35 Senate seats. For bond prices, the result comes down to one thing: how much the government will borrow over the next two years.

The US Dollar fell. Gold didn't rally. That tells you everything

Gold (XAU/USD) is struggling to capitalize on a weaker US Dollar (USD), after repeatedly failing to establish itself above the $4,200 level. The precious metal remains confined to a relatively narrow trading range despite a combination of developments that would normally support higher prices.